Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1974 1
1976 1
1980 1
1991 1
1992 1
1996 1
1998 1
2004 2
2010 1
2011 3
2012 2
2013 4
2015 1
2016 2
2017 5
2018 3
2019 2
2020 8
2021 7
2022 6
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Ender nailing.
Askin SR. Askin SR. Orthopedics. 1980 Jun 1;3(6):601. doi: 10.3928/0147-7447-19800601-17. Orthopedics. 1980. PMID: 24823043 No abstract available.
Evolving regulatory perspectives on digital health technologies for medicinal product development.
Colloud S, Metcalfe T, Askin S, Belachew S, Ammann J, Bos E, Kilchenmann T, Strijbos P, Eggenspieler D, Servais L, Garay C, Konstantakopoulos A, Ritzhaupt A, Vetter T, Vincenzi C, Cerreta F. Colloud S, et al. Among authors: askin s. NPJ Digit Med. 2023 Mar 29;6(1):56. doi: 10.1038/s41746-023-00790-2. NPJ Digit Med. 2023. PMID: 36991116 Free PMC article. Review.
Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS, Ekinci Akdemir FN, Yildirim S, Sahin A, Eser G, Askin S. Gozeler MS, et al. Among authors: askin s. Int J Pediatr Otorhinolaryngol. 2019 Jul;122:70-75. doi: 10.1016/j.ijporl.2019.04.004. Epub 2019 Apr 5. Int J Pediatr Otorhinolaryngol. 2019. PMID: 30978472
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective.
de Jong AJ, van Rijssel TI, Zuidgeest MGP, van Thiel GJMW, Askin S, Fons-Martínez J, De Smedt T, de Boer A, Santa-Ana-Tellez Y, Gardarsdottir H; Trials@Home Consortium. de Jong AJ, et al. Among authors: askin s. Clin Pharmacol Ther. 2022 Aug;112(2):344-352. doi: 10.1002/cpt.2628. Epub 2022 May 17. Clin Pharmacol Ther. 2022. PMID: 35488483 Free PMC article.
Development of a Series of Pyrrolopyridone MAT2A Inhibitors.
Atkinson SJ, Bagal SK, Argyrou A, Askin S, Cheung T, Chiarparin E, Coen M, Collie IT, Dale IL, De Fusco C, Dillman K, Evans L, Feron LJ, Foster AJ, Grondine M, Kantae V, Lamont GM, Lamont S, Lynch JT, Nilsson Lill S, Robb GR, Saeh J, Schimpl M, Scott JS, Smith J, Srinivasan B, Tentarelli S, Vazquez-Chantada M, Wagner D, Walsh JJ, Watson D, Williamson B. Atkinson SJ, et al. Among authors: askin s. J Med Chem. 2024 Mar 28;67(6):4541-4559. doi: 10.1021/acs.jmedchem.3c01860. Epub 2024 Mar 11. J Med Chem. 2024. PMID: 38466661
Digital technologies for medicines: shaping a framework for success.
Cerreta F, Ritzhaupt A, Metcalfe T, Askin S, Duarte J, Berntgen M, Vamvakas S. Cerreta F, et al. Among authors: askin s. Nat Rev Drug Discov. 2020 Sep;19(9):573-574. doi: 10.1038/d41573-020-00080-6. Nat Rev Drug Discov. 2020. PMID: 32398879 No abstract available.
57 results